Left bundle branch block is not good for your heart

Heart Rhythm

Volumn 4, Issue 3, 2007, Pages 314-315

  Ott, Peter ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; VALSARTAN;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONGESTIVE HEART FAILURE; DEFIBRILLATION; DISEASE CLASSIFICATION; EDITORIAL; ELECTROCARDIOGRAPHY; EXERCISE TOLERANCE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MONOTHERAPY; MORTALITY; PRIORITY JOURNAL; SAMPLE SIZE; SUDDEN DEATH; SURVIVOR; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BUNDLE-BRANCH BLOCK; CAPTOPRIL; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS; STROKE VOLUME; TETRAZOLES; TIME FACTORS; VALINE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33847270330     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.12.002     Document Type: Editorial

References (13)

1. Rodriguez L.M., Timmermans C., Nabar A., Beatty G., and Wellens H.J.J. Variable patterns of septal activation in patients with left bundle branch block and heart failure. J Cardiovasc Electrophysiol 14 (2003) 135-141
2. Wiggers C.J. The muscular reactions of the mammalian ventricles to artificial stimulation. Am J Physiol 73 (1925) 346
3. Vasallo J.A., Cassidy D.M., Marschlinski F.E., Buxton A.E., Waxman H.L., Doherty J.U., and Josephson M.E. Endocardial activation of left bundle branch block. Circulation 69 (1984) 914-923
4. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., DeMarco T., Carson P., DiCarlo L., DeMets D., White B.G., DeVries D.W., Feldman P., Comparison of Medical Therapy, and Pacing and Defibrillator in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
5. Cleland J.G.F., Daubert J.C., Erdmann E., Freemantle N., Gras D., Kappenberger L., Tavazzi L., and Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
6. Willkoff B.L., Cook J.R., Epstein A.E., Greene H.L., Hallstrom A.P., Hsia H., Kutalek S.P., and Sharma A. Dual chamber pacing or ventricular back up pacing in patients with an implantable defibrillator: the Dual chamber and VVI Implantable Defibrillator (DAVID) trial. JAMA 288 (2002) 3115-3123
7. Lamas G.A., Lee K.L., Sweeney M.O., Silverman R., Leon A., Yee R., Marinchak R.A., Flaker G., Schron E., Orav J., Hellkamp A.S., Greer S., McAnulty J., Ellenbogen K., Ehlert F., Freedman R.A., Estes M.N.A., Greenspon A., Goldman L., and Mode Selection Trial in Sinus-Node Dysfunction. Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction. N Engl J Med 346 (2002) 1854-1862
8. Sharma A.D., Rizo-Patron C., Hallstrom A., O'Neill G.P., Rothbart S., Martins J.B., Roelke M., Steinberg J.S., Greene H.L., and DAVID investigators. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2 (2005) 830-834
9. Sweeney M.O., Hellkamp A.S., Ellenbogen K.A., Greenspon A.J., Freedman R.A., Lee K.L., Lamas G.A., and MOde Selection Trial (MOST) Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107 (2003) 2932-2937
10. Shukla H.H., Hellkamp A.S., James E.A., Flaker C.G., Lee K.L., Sweeney M.O., Lamas G.A., and Mode Selection Trial (MOST) Investigators. Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration. Heart Rhythm 2 (2005) 245-251
11. Go A.S., Barron H.V., Rundle A.C., Ornato J.P., and Avins A. Bundle-branch block and in-hospital mortality in acute myocardial infarction. Ann Intern Med 129 (1998) 690-697
12. Stephenson K., Skali H., McMurray J.J.V., Velazquez E.J., Aylward P.G., Kober L., Van de Werf F., White H.D., Pieper K.S., Califf R.M., Solomon S.D., and Pfeffer M.A. Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: The VALIANT experience. Heart Rhythm 4 (2007) 308-313
13. Pfeffer M.A., McMurray J.J.V., Velazquez E.J., Rouleau J.L., Kober L., Maggioni A.P., Solomon S.D., Swedberg K., McMurray J.J.V., Van de Werf F., White H.D., Leimberger J.D., Henis M., Edwards S., Zelenkofske S., Selleres M.A., Califf R.M., and Valsartan in acute myocardial infraction trial investigators. Valsartan, captopril or both in myocardial infarction complicated by heart failure, left ventricular dysfunction or both. N Engl J Med 349 (2003) 1893-1906